Abstract
Antimicrobial resistant bacteria have grown sharply in recent years, a fact that has favored the increase in mortality and morbidity. During the COVID-19 pandemic, this problem was intensified, with a significant increase in multidrug resistant (MDR) bacteria and, mainly, in carbapenemase-producing strains. Acinetobacter baumannii and Pseudomonas aeruginosa strains carbapenem resistant an…